Company page

Advicenne Sa

Advicenne SA is a public company listed on the French market under the ticker ALDVI, with a market capitalization of approximately €26.16 million. The company focuses on developing innovative treatments for patients with rare kidney diseases. Advicenne aims to address unmet medical needs through its specialized pharmaceutical products.